[Cryptococcal disease and immunosuppressive treatment].
Riera-Mestre
Antoni
A
de la Haba-Vacas
Irma
I
Vidaller-Palacín
Antonio
A
Fernández-Viladrich
Pedro
P
D000369:Aged, 80 and over; D004198:Disease Susceptibility; D005260:Female; D018023:HIV Seronegativity; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D016031:Liver Transplantation; D008297:Male; D016919:Meningitis, Cryptococcal / Q000134:cerebrospinal fluid / Q000175:diagnosis / Q000209:etiology*; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D009894:Opportunistic Infections / Q000134:cerebrospinal fluid / Q000175:diagnosis / Q000209:etiology*; D010488:Polyarteritis Nodosa / Q000150:complications / Q000188:drug therapy; D011183:Postoperative Complications / Q000209:etiology; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid; D011241:Prednisone